CD274 and neoplasm: Tumor samples scored by PD-L1 expression in TC or IC similarly revealed an association between high-PD-L1 expression and longer OS in the ramucirumab arm (TC ≥ 1 vs. <1, 9.2 vs. 7.89 months, Fig. 1b; IC ≥ 4 vs. <4, 9.2 vs. 7.92 months, Fig. 1c).